09995.HK香港交易所 · 主板 Main
Remegen 榮昌生物
Pharmaceuticals and Biotechnology 药品及生物科技
HK$71.75−HK$1.15 · −1.58%
Open 开盘
HK$72.90
High 最高
HK$73.05
Low 最低
HK$71.00
Prev Close 昨收
HK$72.90
Volume 成交量
114.8万股
Turnover 成交额
HK$8,291.1万
Mkt Cap 总市值
HK$405亿
P/E 市盈率
51.5×
Recent Activity 近期动态All Filings 全部公告 →
8 significant filings since 31 May 2026: 6 on buyback, 1 on earnings pre-announcement and 1 on new listing. The latest, on 2 Sep 2026: 海外监管公告 - 关于2026年第一次以集中竞价交易方式回购公司股份的进展公告.
自 31 May 2026 起有 8 份重大公告：buyback 6 份、earnings pre-announcement 1 份、new listing 1 份。最新一份（2 Sep 2026）：海外监管公告 - 关于2026年第一次以集中竞价交易方式回购公司股份的进展公告。
255075100125
Volume 成交量
4,820.1万
20202022202320252026
Key Metrics 核心指标
Reporting Period 报告期 · 30 Jun 2026 中报
Revenue 营业收入
¥59亿
YoY 同比 +435.74%
Net Profit 净利润
¥47亿
YoY 同比 +1,137.06%
Gross Margin
毛利率
The share of each sale left after the direct cost of making the product. It shows pricing power before overheads, marketing and tax.
每笔销售扣除直接生产成本后剩下的比例，反映管理费用、营销和税之前的定价能力。In This Case 本例中Gross margin was 95.40% for the period to 30 Jun 2026 中报. Direction matters more than level, and a widening lead over peers signals a durable advantage.
方向比水平更重要，与同业差距持续拉大说明优势稳固。
每笔销售扣除直接生产成本后剩下的比例，反映管理费用、营销和税之前的定价能力。In This Case 本例中Gross margin was 95.40% for the period to 30 Jun 2026 中报. Direction matters more than level, and a widening lead over peers signals a durable advantage.
方向比水平更重要，与同业差距持续拉大说明优势稳固。
95.40%
Net Margin
净利率
The share of revenue left as profit after all costs, interest and tax.
扣除全部成本、利息和税后，营收中剩下的利润比例。In This Case 本例中Net margin was 79.69% for the period to 30 Jun 2026 中报, ¥47亿 of net profit on ¥59亿 of revenue. Compare within one industry, because a supermarket at 3% can be healthier than a software company at 15%.
只在同行业内比较：3% 的超市可能比 15% 的软件公司更健康。
扣除全部成本、利息和税后，营收中剩下的利润比例。In This Case 本例中Net margin was 79.69% for the period to 30 Jun 2026 中报, ¥47亿 of net profit on ¥59亿 of revenue. Compare within one industry, because a supermarket at 3% can be healthier than a software company at 15%.
只在同行业内比较：3% 的超市可能比 15% 的软件公司更健康。
79.69%
Return on Equity
净资产收益率
The profit the company produced in the year for every 100 yuan that shareholders have in the business.
公司一年内为股东投入的每 100 元所赚取的利润。In This Case 本例中ROE was 78.21% for the period to 30 Jun 2026 中报. A sustained 15% or more is good, provided it is not propped up by heavy borrowing.
持续 15% 以上为佳，前提是不靠高负债撑起来。
公司一年内为股东投入的每 100 元所赚取的利润。In This Case 本例中ROE was 78.21% for the period to 30 Jun 2026 中报. A sustained 15% or more is good, provided it is not propped up by heavy borrowing.
持续 15% 以上为佳，前提是不靠高负债撑起来。
78.21%
Not annualised
Debt Ratio
资产负债率
Total liabilities as a percentage of total assets. At 60%, lenders have funded three yuan of the business for every two from the owners.
总负债占总资产的百分比。60% 意味着贷款方每出三元，股东出两元。In This Case 本例中Total liabilities were 15.57% of total assets at 30 Jun 2026 中报. Read it against the industry, as a bank sits above 90% and a distiller below 30%.
要对照行业来看：银行常在 90% 以上，白酒企业则在 30% 以下。
总负债占总资产的百分比。60% 意味着贷款方每出三元，股东出两元。In This Case 本例中Total liabilities were 15.57% of total assets at 30 Jun 2026 中报. Read it against the industry, as a bank sits above 90% and a distiller below 30%.
要对照行业来看：银行常在 90% 以上，白酒企业则在 30% 以下。
15.57%
Cash Flow to Revenue
经营现金流/营收
Cash the business collected from trading, as a multiple of the revenue it booked.
经营活动收到的现金与账面营收之比。 A figure well below the net margin, period after period, means sales are being booked faster than they are paid for.
如果连续多期明显低于净利率，说明销售确认快于回款。
经营活动收到的现金与账面营收之比。 A figure well below the net margin, period after period, means sales are being booked faster than they are paid for.
如果连续多期明显低于净利率，说明销售确认快于回款。
—